Carl Icahn digs in on his criticism of eBay's management and weighs in on Bill Ackman again.» Read More
March 10- William Ackman's hedge fund Pershing Square Capital Management LP said it would unveil on Tuesday details about Herbalife Ltd's violations in China as the activist investor sharpened his attack against the nutritional products company.
BOSTON, Feb 28- The U.S. Federal Trade Commission on Friday refused to tip its hand on how it may be react to allegations that Herbalife is a fraud, but said it is taking a lawmaker's concerns about the company seriously and underscored its record of shutting down pyramid schemes.
BOSTON, Feb 28- Billionaire investor William Ackman, who has long claimed Herbalife Ltd is a fraud, on Friday said he would provide proof next month that the nutrition and weight-loss company is running a pyramid scheme in China.
Feb 24- A U.S. district court in Utah has frozen the assets of several Internet business coaches accused of lying to customers about their potential earnings after signing up for the services, the Federal Trade Commission said on Monday.
CNBC.com's Lawrence Delevingne discusses Herbalife's 49 percent fall in 2013.
Virtually everyone on Wall Street knows that Ackman's Herbalife bet has cost him so far. Now we know exactly how much.
BOSTON, Feb 20- Herbalife executives will meet with U.S. lawmakers' staffs in Washington on Friday to explain the business model of the nutrition company that has been fending off accusations by billionaire investor William Ackman that it is running a pyramid scheme.
Are big bank leaders like Jamie Dimon the most influential on Wall Street—or activist investors like Carl Icahn?
BOSTON, Feb 19- Nutrition and weight loss products company Herbalife Ltd lowered its forecast range for 2014 sales and again defended itself on Wednesday against allegations by billionaire investor William Ackman that its business is a fraud.
Stocks finished near session lows in volatile trading Wednesday, with the Nasdaq snapping an eight-day winning streak, as investors digested minutes from the Fed's latest policy meeting.
*U.S. housing starts, permits tumble in January. NEW YORK, Feb 19- U.S. stocks edged lower on Wednesday with the S&P 500 facing technical resistance near its record high, while economic data continued to be blurred by extreme weather. Goldman Sachs lowered its first-quarter growth estimate by a tenth of a percentage point to a 1.8 percent annual rate.
*Fed minutes due at 2:00 p.m. EST. NEW YORK, Feb 19- U.S. stocks declined on Wednesday in midday trading as the S&P 500 faced a technical resistance level after a recent string of gains and investors turned cautious ahead of the release of the minutes from the Federal Reserve's latest policy meeting.
NEW YORK, Feb 19- U.S. stocks were mixed on Wednesday amid caution ahead of the release of minutes from the Federal Reserve's most recent policy meeting, and as investors brushed off weak housing data. The Dow Jones industrial average index rebounded after underperforming the broader market in the previous session, led by gains in Chevron and American Express.
NEW YORK, Feb 19- Wall Street was set to open lower on Wednesday amid caution ahead of the release of minutes from the Federal Reserve's most recent policy meeting, even as investors brushed off weak housing data.
Some of the names on the move ahead of the open.
Feb 18- Herbalife Ltd, the nutrition products company accused by billionaire investor William Ackman of being a pyramid scheme, raised its forecast for the first quarter of 2014 on strong sales growth in China.
*Forest Labs shares soar; Actavis agrees to buy company. NEW YORK, Feb 18- The S&P 500 and Nasdaq rose on Tuesday, following Wall Street's biggest weekly gain of the year, as merger activity increased confidence that there is value in the stock market even as the benchmark index nears a record high.
Feb 18- Herbalife Ltd, the nutrition products company accused by investor William Ackman of being a pyramid scheme, raised its current-quarter adjusted profit forecast as demand for its weight-loss products held up.
Companies making headlines after the bell Tuesday.
CNBC contributor Herb Greenberg, and Brian Bolan, Zacks Investment Research, provide reaction to Herbalife's earnings and dissect its business model.